| Bioactivity | Gypenoside LXXV, isolated from Gynostemma pentaphyllum, is one of the deglycosylated shapes of ginsenoside Rb1. Gypenoside LXXV significantly reduces cancer cell viability and displays an anti-cancer effect[1]. |
| Invitro | Gypenoside LXXV (1.0-100 μM; for 48 hours) reduces proliferation in a dose-dependent manner[1]. Cell Viability Assay[1] Cell Line: |
| Name | Gypenoside LXXV |
| CAS | 110261-98-8 |
| Formula | C42H72O13 |
| Molar Mass | 785.01 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, protect from light *In solvent : -80°C, 6 months; -20°C, 1 month (protect from light) |
Gypenoside LXXV
CAS: 110261-98-8 F: C42H72O13 W: 785.01
Gypenoside LXXV, isolated from Gynostemma pentaphyllum, is one of the deglycosylated shapes of ginsenoside Rb1. Gypenosi
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.